|
1
|
Ueda SM, Kapp DS, Cheung MK, Shin JY,
Osann K, Husain A, Teng NN, Berek JS and Chan JK: Trends in
demographic and clinical characteristics in women diagnosed with
corpus cancer and their potential impact on the increasing number
of deaths. Am J Obstet Gynecol. 198:218.e1–218.e6. 2008. View Article : Google Scholar
|
|
2
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y,
et al: Reduced expression of the let-7 microRNAs in human lung
cancers in association with shortened postoperative survival.
Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bou Kheir T, Futoma-Kazmierczak E,
Jacobsen A, Krogh A, Bardram L, Hother C, Grønbæk K, Federspiel B,
Lund AH and Friis-Hansen L: miR-449 inhibits cell proliferation and
is down-regulated in gastric cancer. Mol Cancer. 10:292011.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Esquela-Kerscher A and Slack FJ: Oncomirs
- microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jiang F, Liu T, He Y, Yan Q, Chen X, Wang
H and Wan X: MiR-125b promotes proliferation and migration of type
II endometrial carcinoma cells through targeting TP53INP1 tumor
suppressor in vitro and in vivo. BMC Cancer. 11:4252011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tsuruta T, Kozaki K, Uesugi A, Furuta M,
Hirasawa A, Imoto I, Susumu N, Aoki D and Inazawa J: miR-152 is a
tumor suppressor microRNA that is silenced by DNA hypermethylation
in endometrial cancer. Cancer Res. 71:6450–6462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Le XF, Merchant O, Bast RC and Calin GA:
The roles of microRNAs in the cancer invasion-metastasis cascade.
Cancer Microenviron. 3:137–147. 2010. View Article : Google Scholar
|
|
9
|
Ye W, Xue J, Zhang Q, Li F, Zhang W, Chen
H, Huang Y and Zheng F: miR-449a functions as a tumor suppressor in
endometrial cancer by targeting CDC25A. Oncol Rep. 32:1193–1199.
2014.PubMed/NCBI
|
|
10
|
Wong MY, Yu Y, Walsh WR and Yang JL:
microRNA-34 family and treatment of cancers with mutant or
wild-type p53 (Review). Int J Oncol. 38:1189–1195. 2011.PubMed/NCBI
|
|
11
|
Son MS, Jang MJ, Jeon YJ, Kim WH, Kwon CI,
Ko KH, Park PW, Hong SP, Rim KS, Kwon SW, et al: Promoter
polymorphisms of pri-miR-34b/c are associated with hepatocellular
carcinoma. Gene. 524:156–160. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Roy S, Levi E, Majumdar AP and Sarkar FH:
Expression of miR-34 is lost in colon cancer which can be
re-expressed by a novel agent CDF. J Hematol Oncol. 5:582012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oeggerli M, Tomovska S, Schraml P,
Calvano-Forte D, Schafroth S, Simon R, Gasser T, Mihatsch MJ and
Sauter G: E2F3 amplification and overexpression is associated with
invasive tumor growth and rapid tumor cell proliferation in urinary
bladder cancer. Oncogene. 23:5616–5623. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ziebold U, Reza T, Caron A and Lees JA:
E2F3 contributes both to the inappropriate proliferation and to the
apoptosis arising in Rb mutant embryos. Genes Dev. 15:386–391.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hiroki E, Suzuki F, Akahira J, Nagase S,
Ito K, Sugawara J, Miki Y, Suzuki T, Sasano H and Yaegashi N:
MicroRNA-34b functions as a potential tumor suppressor in
endometrial serous adenocarcinoma. Int J Cancer. 131:E395–E404.
2012. View Article : Google Scholar
|
|
16
|
Jiang L, Meng W, Zeng J, Hu H and Lu L:
MiR-34c oligonucleotide enhances chemosensitivity of Ishikawa cell
to cisplatin by inducing apoptosis. Cell Biol Int. 37:577–583.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kubo T, Toyooka S, Tsukuda K, Sakaguchi M,
Fukazawa T, Soh J, Asano H, Ueno T, Muraoka T, Yamamoto H, et al:
Epigenetic silencing of microRNA-34b/c plays an important role in
the pathogenesis of malignant pleural mesothelioma. Clin Cancer
Res. 17:4965–4974. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Toyota M, Suzuki H, Sasaki Y, Maruyama R,
Imai K, Shinomura Y and Tokino T: Epigenetic silencing of
microRNA-34b/c and B-cell translocation gene 4 is associated with
CpG island methylation in colorectal cancer. Cancer Res.
68:4123–4132. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
He L, He X, Lim LP, de Stanchina E, Xuan
Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, et al: A microRNA
component of the p53 tumour suppressor network. Nature.
447:1130–1134. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen HZ, Tsai SY and Leone G: Emerging
roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev
Cancer. 9:785–797. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Timmers C, Sharma N, Opavsky R, Maiti B,
Wu L, Wu J, Orringer D, Trikha P, Saavedra HI and Leone G: E2f1,
E2f2, and E2f3 control E2F target expression and cellular
proliferation via a p53-dependent negative feedback loop. Mol Cell
Biol. 27:65–78. 2007. View Article : Google Scholar :
|
|
22
|
Lax SF, Kendall B, Tashiro H, Slebos RJ
and Hedrick L: The frequency of p53, K-ras mutations, and
microsatellite instability differs in uterine endometrioid and
serous carcinoma: evidence of distinct molecular genetic pathways.
Cancer. 88:814–824. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Corney DC, Flesken-Nikitin A, Godwin AK,
Wang W and Nikitin AY: MicroRNA-34b and microRNA-34c are targets of
p53 and cooperate in control of cell proliferation and
adhesion-independent growth. Cancer Res. 67:8433–8438. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Foster CS, Falconer A, Dodson AR, Norman
AR, Dennis N, Fletcher A, Southgate C, Dowe A, Dearnaley D, Jhavar
S, et al: Transcription factor E2F3 overexpressed in prostate
cancer independently predicts clinical outcome. Oncogene.
23:5871–5879. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leone G, DeGregori J, Yan Z, Jakoi L,
Ishida S, Williams RS and Nevins JR: E2F3 activity is regulated
during the cell cycle and is required for the induction of S phase.
Genes Dev. 12:2120–2130. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Migliore C, Petrelli A, Ghiso E, Corso S,
Capparuccia L, Eramo A, Comoglio PM and Giordano S: MicroRNAs
impair MET-mediated invasive growth. Cancer Res. 68:10128–10136.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Z, Gou J and Xu J: Down-regulation of
focal adhesion signaling in response to cyclophilin A knockdown in
human endometrial cancer cells, implicated by cDNA microarray
analysis. Gynecol Oncol. 131:191–197. 2013. View Article : Google Scholar : PubMed/NCBI
|
